Securities Code: 000972
Securities Abbreviation: Zhongji Health
Announcement No.: 2026-047
Zhongji Health Industry Co., Ltd.
Announcement on Abnormal Stock Trading Fluctuations
The Company and all members of the Board of Directors guarantee the content of the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
I. Specifics of Abnormal Stock Trading Fluctuations
The stock of Zhongji Health Industry Co., Ltd. (hereinafter referred to as the "Company" or "Zhongji Health") (Securities Abbreviation: Zhongji Health, Securities Code: 000972) experienced a cumulative closing price increase of 20.32% on July 1st, 2026, and July 2nd, 2026, for two consecutive trading days. In accordance with the relevant provisions of the "Trading Rules of Shenzhen Stock Exchange," this constitutes an abnormal stock trading fluctuation.
II. Company's Attention and Verification of Relevant Information
Regarding the abnormal stock trading fluctuations, the Company has investigated the relevant matters as required by the regulations and provides the following verification:
-
The Company's self-inspection indicates that the Company's recent production and operation situation is normal, and there have been no major changes in the internal and external operating environment.
-
Information previously disclosed does not require correction or supplementation.
-
As audited by Zhongxinghua Certified Public Accountants (Special General Partnership), as of the end of 2025, the equity attributable to shareholders of the listed company was RMB 26.1223 million, turning from negative to positive. Concurrently, the operating income after deduction for 2025 was RMB 488 million, and the net profit attributable to shareholders of the listed company was RMB -46.2318 million. According to Article 9.3.8 of the "Shenzhen Stock Exchange Stock Listing Rules," if a listed company's stock trading is subject to a delisting risk warning due to the circumstances stipulated in the first paragraph of Article 9.3.1 of these Rules, and the annual report for the year following the year in which the delisting risk warning was triggered indicates that the company does not have any of the circumstances stipulated in Articles 9.3.12, items one to seven of these Rules, the company may apply to the Exchange to lift the delisting risk warning. The Company's self-inspection indicates that the Company's 2025 annual report does not contain any of the circumstances stipulated in Article 9.3.12, items one to seven of the "Stock Listing Rules," nor does it contain other circumstances requiring a delisting risk warning or other risk warnings as stipulated in the "Shenzhen Stock Exchange Stock Listing Rules (2026 Revision)." The Company meets the conditions for applying to lift the delisting risk warning. The Company's stock trading will have the delisting risk warning lifted starting from June 29th, 2026 (Monday), and the stock abbreviation will change from "*ST Zhongji" to "Zhongji Health," with the stock code remaining "000972."